ATOSSA THERAPEUTICS, INC. (ATOS) Operating income 2016–2025
ATOSSA THERAPEUTICS, INC. (ATOS) annual operating income history from SEC filings — each fiscal year as reported.
-$37.1MFY2025 · since FY2016: -$8.0M → -$37.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.1M | -34.5% |
| FY2024 | -$27.6M | +12.0% |
| FY2023 | -$31.4M | -13.3% |
| FY2022 | -$27.7M | -34.9% |
| FY2021 | -$20.5M | -40.5% |
| FY2020 | -$14.6M | +15.4% |
| FY2019 | -$17.3M | -51.0% |
| FY2018 | -$11.4M | -49.5% |
| FY2017 | -$7.6M | +4.0% |
| FY2016 | -$8.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice